Galapagos NV (NASDAQ:GLPG) was upgraded by investment analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued to investors on Wednesday.

A number of other brokerages also recently issued reports on GLPG. Janney Montgomery Scott downgraded Galapagos NV from a “buy” rating to a “sell” rating in a research note on Monday, April 24th. Zacks Investment Research downgraded Galapagos NV from a “buy” rating to a “hold” rating in a research note on Tuesday, March 21st. Nomura initiated coverage on Galapagos NV in a research note on Wednesday, March 1st. They set a “buy” rating for the company. Instinet initiated coverage on Galapagos NV in a research note on Wednesday, March 1st. They set a “buy” rating and a $87.00 price objective for the company. Finally, Stifel Nicolaus boosted their price objective on Galapagos NV from $65.00 to $83.00 and gave the company a “hold” rating in a research note on Monday, May 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $74.40.

Analyst Recommendations for Galapagos NV (NASDAQ:GLPG)

Shares of Galapagos NV (NASDAQ:GLPG) traded up 0.46% during mid-day trading on Wednesday, reaching $85.58. The company had a trading volume of 116,617 shares. Galapagos NV has a 1-year low of $49.43 and a 1-year high of $94.88. The firm has a 50-day moving average price of $87.51 and a 200-day moving average price of $72.03. The stock has a market capitalization of $3.96 billion, a price-to-earnings ratio of 855.80 and a beta of 1.85.

TRADEMARK VIOLATION NOTICE: “Galapagos NV (GLPG) Upgraded to “C” by TheStreet” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/05/19/galapagos-nv-glpg-upgraded-to-c-by-thestreet.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of GLPG. Driehaus Capital Management LLC acquired a new position in Galapagos NV during the first quarter worth approximately $942,000. Clough Capital Partners L P boosted its position in Galapagos NV by 336.1% in the first quarter. Clough Capital Partners L P now owns 74,870 shares of the biotechnology company’s stock worth $6,453,000 after buying an additional 57,700 shares in the last quarter. Bank of America Corp DE boosted its position in Galapagos NV by 18.8% in the first quarter. Bank of America Corp DE now owns 4,379 shares of the biotechnology company’s stock worth $377,000 after buying an additional 694 shares in the last quarter. Renaissance Technologies LLC boosted its position in Galapagos NV by 51.4% in the first quarter. Renaissance Technologies LLC now owns 311,200 shares of the biotechnology company’s stock worth $26,822,000 after buying an additional 105,700 shares in the last quarter. Finally, UBS Group AG boosted its position in Galapagos NV by 237.0% in the first quarter. UBS Group AG now owns 3,522 shares of the biotechnology company’s stock worth $303,000 after buying an additional 2,477 shares in the last quarter. 21.08% of the stock is currently owned by institutional investors.

Galapagos NV Company Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

5 Day Chart for NASDAQ:GLPG

Receive News & Ratings for Galapagos NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos NV and related companies with MarketBeat.com's FREE daily email newsletter.